The International Rett Syndrome Foundation (IRSF) announced today that its Clinical Trial Committee (CTC) has launched, having completed its first protocol review, and is available as a resource to ...

Dominique Pichard, M.D., returns as Chief Science Officer, and Staci Almager joins as Chief Development Officer. As the mother of an individual with Rett, I'm honored to rejoin this community at such ...

Dr. Drew Jones, newly appointed VP of Clinical Development at IRSF The new leadership appointments include a key promotion and new hire to advance research and clinical development for Rett syndrome.

Accomplished nonprofit and biotech leader brings decades of rare disease experience to guide IRSF's next chapter of impact and growth. [Laura's] unique blend of scientific insight, policy experience, ...

International Revenue Share Fraud (IRSF), also known as toll fraud, has been around for years, but it’s still a major problem for telcos and, more recently, for digital businesses. IRSF has grown ...

Grants have been awarded to 13 scientific research teams around the globe. This research advances toward our mission of helping every individual impacted by Rett syndrome. With our investment, we are ...

WALTHAM, Mass.--(BUSINESS WIRE)--Lucy Therapeutics (LucyTx) has secured new funding from the International Rett Syndrome Foundation (IRSF) to invest in pioneering treatments for children and adults ...